Determination of some hydroxycholesterols in human serum samples

Area of Science:

• Biochemistry
• Clinical Chemistry
• Metabolomics

Background:

• Hydroxycholesterols are critical intermediates in cholesterol metabolism and bile acid synthesis.
• Disruptions in these pathways are implicated in various metabolic disorders.
• Accurate quantification of specific hydroxycholesterols is essential for diagnosing and understanding these conditions.

Purpose of the Study:

• To develop and validate a method for the simultaneous determination of 7 alpha-hydroxycholesterol, 7 beta-hydroxycholesterol, and 26-hydroxycholesterol in human serum.
• To assess the clinical utility of these hydroxycholesterol measurements in differentiating various metabolic and cholestatic conditions.

Main Methods:

• Serum samples underwent hydrolysis and extraction.
• Cholesterol was removed using reversed-phase high-performance liquid chromatography (RP-HPLC).
• Purified hydroxycholesterols were derivatized to trimethylsilyl ethers and analyzed by gas chromatography with flame ionization detection (GC-FID).

Main Results:

• Serum 7 alpha-hydroxycholesterol levels were found to be a reliable indicator of disorders in the conversion of 7 alpha-hydroxycholesterol to bile acids.
• 26-hydroxycholesterol was undetectable in patients with cerebrotendinous xanthomatosis (CTX), even with effective bile acid therapy.
• Substantial levels of 26-hydroxycholesterol were observed in normal individuals and patients with other investigated conditions.

Conclusions:

• Serum 7 alpha-hydroxycholesterol concentration serves as a valuable biomarker for diagnosing bile acid synthesis defects.
• The absence of detectable 26-hydroxycholesterol in CTX patients distinguishes this condition from other metabolic disorders.
• The developed analytical method provides a robust tool for hydroxycholesterol profiling in clinical diagnostics.